163 related articles for article (PubMed ID: 29615404)
81. Predicting the future for DLBCL.
Cheson BD
Blood; 2020 Apr; 135(16):1308-1309. PubMed ID: 32298441
[No Abstract] [Full Text] [Related]
82. Mouse model of MYD88L265P-dependent DLBCL.
Janz S
Blood; 2016 Jun; 127(22):2660-1. PubMed ID: 27257177
[No Abstract] [Full Text] [Related]
83. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Schmitz R; Wright GW; Huang DW; Johnson CA; Phelan JD; Wang JQ; Roulland S; Kasbekar M; Young RM; Shaffer AL; Hodson DJ; Xiao W; Yu X; Yang Y; Zhao H; Xu W; Liu X; Zhou B; Du W; Chan WC; Jaffe ES; Gascoyne RD; Connors JM; Campo E; Lopez-Guillermo A; Rosenwald A; Ott G; Delabie J; Rimsza LM; Tay Kuang Wei K; Zelenetz AD; Leonard JP; Bartlett NL; Tran B; Shetty J; Zhao Y; Soppet DR; Pittaluga S; Wilson WH; Staudt LM
N Engl J Med; 2018 Apr; 378(15):1396-1407. PubMed ID: 29641966
[TBL] [Abstract][Full Text] [Related]
84. Genetics of diffuse large B-cell lymphoma.
Pasqualucci L; Dalla-Favera R
Blood; 2018 May; 131(21):2307-2319. PubMed ID: 29666115
[TBL] [Abstract][Full Text] [Related]
85. Oncogenic Signaling Pathways in The Cancer Genome Atlas.
Sanchez-Vega F; Mina M; Armenia J; Chatila WK; Luna A; La KC; Dimitriadoy S; Liu DL; Kantheti HS; Saghafinia S; Chakravarty D; Daian F; Gao Q; Bailey MH; Liang WW; Foltz SM; Shmulevich I; Ding L; Heins Z; Ochoa A; Gross B; Gao J; Zhang H; Kundra R; Kandoth C; Bahceci I; Dervishi L; Dogrusoz U; Zhou W; Shen H; Laird PW; Way GP; Greene CS; Liang H; Xiao Y; Wang C; Iavarone A; Berger AH; Bivona TG; Lazar AJ; Hammer GD; Giordano T; Kwong LN; McArthur G; Huang C; Tward AD; Frederick MJ; McCormick F; Meyerson M; ; Van Allen EM; Cherniack AD; Ciriello G; Sander C; Schultz N
Cell; 2018 Apr; 173(2):321-337.e10. PubMed ID: 29625050
[TBL] [Abstract][Full Text] [Related]
86. How Biophysical Forces Regulate Human B Cell Lymphomas.
Apoorva F; Loiben AM; Shah SB; Purwada A; Fontan L; Goldstein R; Kirby BJ; Melnick AM; Cosgrove BD; Singh A
Cell Rep; 2018 Apr; 23(2):499-511. PubMed ID: 29642007
[TBL] [Abstract][Full Text] [Related]
87. Proteomic Profiling of Diffuse Large B-Cell Lymphomas.
Kwiecińska A; Porwit A; Souchelnytskyi N; Kaufeldt A; Larsson C; Bajalica-Lagercrantz S; Souchelnytskyi S
Pathobiology; 2018; 85(4):211-219. PubMed ID: 29617697
[TBL] [Abstract][Full Text] [Related]
88. Germinal center antibody mutation trajectories are determined by rapid self/foreign discrimination.
Burnett DL; Langley DB; Schofield P; Hermes JR; Chan TD; Jackson J; Bourne K; Reed JH; Patterson K; Porebski BT; Brink R; Christ D; Goodnow CC
Science; 2018 Apr; 360(6385):223-226. PubMed ID: 29650674
[TBL] [Abstract][Full Text] [Related]
89. Uhrf1 regulates germinal center B cell expansion and affinity maturation to control viral infection.
Chen C; Zhai S; Zhang L; Chen J; Long X; Qin J; Li J; Huo R; Wang X
J Exp Med; 2018 May; 215(5):1437-1448. PubMed ID: 29618490
[TBL] [Abstract][Full Text] [Related]
90. Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses.
Vermeulen R; Saberi Hosnijeh F; Bodinier B; Portengen L; Liquet B; Garrido-Manriquez J; Lokhorst H; Bergdahl IA; Kyrtopoulos SA; Johansson AS; Georgiadis P; Melin B; Palli D; Krogh V; Panico S; Sacerdote C; Tumino R; Vineis P; Castagné R; Chadeau-Hyam M; ; Botsivali M; Chatziioannou A; Valavanis I; Kleinjans JCS; de Kok TMCM; Keun HC; Athersuch TJ; Kelly R; Lenner P; Hallmans G; Stephanou EG; Myridakis A; Kogevinas M; Fazzo L; De Santis M; Comba P; Bendinelli B; Kiviranta H; Rantakokko P; Airaksinen R; Ruokojarvi P; Gilthorpe M; Fleming S; Fleming T; Tu YK; Lundh T; Chien KL; Chen WJ; Lee WC; Kate Hsiao C; Kuo PH; Hung H; Liao SF
Int J Cancer; 2018 Sep; 143(6):1335-1347. PubMed ID: 29667176
[TBL] [Abstract][Full Text] [Related]
91. TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma.
Jethwa A; Słabicki M; Hüllein J; Jentzsch M; Dalal V; Rabe S; Wagner L; Walther T; Klapper W; ; Bohnenberger H; Rettel M; Lu J; Smits AH; Stein F; Savitski MM; Huber W; Aylon Y; Oren M; Zenz T
Blood; 2018 Jun; 131(25):2789-2802. PubMed ID: 29653964
[TBL] [Abstract][Full Text] [Related]
92. Frontline treatment of diffuse large B-cell lymphoma in elderly: a systematic review of clinical trials in post-rituximab era.
Beygi S; Sadashiv S; Reilly JB; Khan C; Lister J
Leuk Lymphoma; 2018 Dec; 59(12):2847-2861. PubMed ID: 29616868
[TBL] [Abstract][Full Text] [Related]
93. A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.
Bachy E; Maurer MJ; Habermann TM; Gelas-Dore B; Maucort-Boulch D; Estell JA; Van den Neste E; Bouabdallah R; Gyan E; Feldman AL; Bargay J; Delmer A; Slager SL; Gomes da Silva M; Fitoussi O; Belada D; Maisonneuve H; Intragumtornchai T; Ansell SM; Lamy T; Dartigues P; Link BK; Seymour JF; Cerhan JR; Salles G
Blood; 2018 Jul; 132(1):49-58. PubMed ID: 29666118
[TBL] [Abstract][Full Text] [Related]
94. Methodology of clinical trials evaluating the incorporation of new drugs in the first-line treatment of patients with diffuse large B-cell lymphoma (DLBCL): a critical review.
Iacoboni G; Zucca E; Ghielmini M; Stathis A
Ann Oncol; 2018 May; 29(5):1120-1129. PubMed ID: 29659676
[TBL] [Abstract][Full Text] [Related]
95. Loss of KLHL6 promotes diffuse large B-cell lymphoma growth and survival by stabilizing the mRNA decay factor roquin2.
Choi J; Lee K; Ingvarsdottir K; Bonasio R; Saraf A; Florens L; Washburn MP; Tadros S; Green MR; Busino L
Nat Cell Biol; 2018 May; 20(5):586-596. PubMed ID: 29695787
[TBL] [Abstract][Full Text] [Related]
96. Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells.
He X; Kläsener K; Iype JM; Becker M; Maity PC; Cavallari M; Nielsen PJ; Yang J; Reth M
EMBO J; 2018 Jun; 37(11):. PubMed ID: 29669863
[TBL] [Abstract][Full Text] [Related]
97. Critical influences on the pathogenesis of follicular lymphoma.
Küppers R; Stevenson FK
Blood; 2018 May; 131(21):2297-2306. PubMed ID: 29666116
[TBL] [Abstract][Full Text] [Related]
98. Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions.
Puente XS; Jares P; Campo E
Blood; 2018 May; 131(21):2283-2296. PubMed ID: 29666114
[TBL] [Abstract][Full Text] [Related]
99. A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group.
Pardal E; Díez Baeza E; Salas Q; García T; Sancho JM; Monzón E; Moraleda JM; Córdoba R; de la Cruz F; Queizán JA; Rodríguez MJ; Navarro B; Hernández JA; Díez R; Vahi M; Viguria MC; Canales M; Peñarrubia MJ; González-López TJ; Montes-Moreno S; González-Barca E; Caballero D; Martín A;
Am J Hematol; 2018 Jul; 93(7):867-873. PubMed ID: 29658143
[TBL] [Abstract][Full Text] [Related]
100. Tight regulation of FOXO1 is essential for maintenance of B-cell precursor acute lymphoblastic leukemia.
Wang F; Demir S; Gehringer F; Osswald CD; Seyfried F; Enzenmüller S; Eckhoff SM; Maier T; Holzmann K; Debatin KM; Wirth T; Meyer LH; Ushmorov A
Blood; 2018 Jun; 131(26):2929-2942. PubMed ID: 29622548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
